J.P. Morgan Healthcare Confab Live Blog: Day One

SAN FRANCISCO ( TheStreet) -- It's Day One of the 31st annual J.P. Morgan Healthcare Conference. Welcome to TheStreet's live-blog coverage which today will include presentations from Celgene ( CELG) , Onyx Pharma ( ONXX), Amarin ( AMRN) and Biogen Idec ( BIIB), just to name a few.

Here's how this live blog is going to (hopefully) work: I will be posting news updates and analysis throughout the day, live from the presentation rooms and breakout (Q&A) sessions. You can also follow me on Twitter, my handle is @adamfeuerstein.

Your best bet is to check back into the live blog several times throughout the day. Feel free to ping me with questions and comments. I'll do my best to respond and keep the live blog as interactive as possible

Here's my planned schedule for Monday, subject to change, of course. All times Eastern and don't ask how I'm going to manage to be in two places at one time. I haven't figured that out yet:

11 am: Celgene
12:30 pm: Onyx Pharma
1 pm: Vertex Pharma ( VRTX)
1:30 pm: Biomarin ( BMRN)
2:30 pm: Amarin
5:30 pm: Biogen Idec and Vivus ( VVUS)
6:30 pm: Gilead Sciences and Dendreon ( DNDN)
7:30 pm: Medivation ( MDVN) and Ariad Pharma ( ARIA).

-- Reported by Adam Feuerstein in Boston.

Adam Feuerstein writes regularly for TheStreet. In keeping with company editorial policy, he doesn't own or short individual stocks, although he owns stock in TheStreet. He also doesn't invest in hedge funds or other private investment partnerships. Feuerstein appreciates your feedback; click here to send him an email.

If you liked this article you might like

How I've Prepared for Hurricane Irma -- and a Market Pullback

How I'm Prepared for Irma -- and a Pullback

Juno, bluebird In Focus as Targets Following Gilead-Kite Aquisition

Apple Is the Tom Brady of Stocks: Cramer's 'Mad Money' Recap (Thursday 8/31/17)

Cramer: Fantasy Shmantasy -- Let's Get Real With These Stock Picks